Autologous Adipose Tissue-Derived Mesenchymal Stem Cell Therapy(Bangabandhu Sheikh Mujib Medical University)

N/A

Report date: 2023/03/27 20:00:44

Base Information

Drug NameAutologous Adipose Tissue-Derived Mesenchymal Stem Cell Therapy(Bangabandhu Sheikh Mujib Medical University)

Drug Alias NameTOST(Bangabandhu Sheikh Mujib Medical University)Adipose-tissue-derived Total-Stromal-cells (Bangabandhu Sheikh Mujib Medical University)AT-MSCs(Bangabandhu Sheikh Mujib Medical University)

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionCell replacements

TargetsUpdating

Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBangladesh

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesBangabandhu Sheikh Mujib Medical University

China Registration ClassN/A

Develop Information

Active CompaniesDhaka Medical College Bangabandhu Sheikh Mujib Medical University

Inactive CompaniesN/A

Active IndicationsOsteoarthritis, KneeOsteoarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A